4.4 Review

Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives

Journal

CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 23, Issue 12, Pages 1090-1103

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026623666230522103321

Keywords

Cancer metabolism; Fatty acid synthesis; Beta-oxidation; Lipid signaling; Lipid metabolism inhibitors; Phospholipids

Ask authors/readers for more resources

It is well-known that cancer cells undergo metabolic reprogramming, especially in lipid metabolism, to support their survival and aggressive behavior. This altered lipid metabolism provides the necessary energy and building blocks for uncontrolled cell proliferation, immune evasion, tumor formation, angiogenesis, metastasis, and invasion. The dysregulation of lipid metabolism has been identified as a potential target for novel anti-cancer therapies and prognostic indicators for various tumor types.
It is now an undisputed fact that cancer cells undergo metabolic reprogramming to support their malignant phenotype, and it is one of the crucial hallmarks which enables cancer cells to facilitate their survival under variable conditions ranging from lack of nutrients to conditions, such as hypoxia. Recent developments in technologies, such as lipidomics and machine learning, have underlined the critical effects of altered lipid metabolism in tumorigenesis. The cancer cells show elevated de novo fatty acid synthesis, an increased capacity to scavenge lipids from their environment, and enhanced fatty acid oxidation to fulfill their need for uncontrolled cellular proliferation, immune evasion, tumor formation, angiogenesis, metastasis, and invasion. Besides, important genes/ proteins involved in lipid metabolism have been proposed as prognostic indicators in a variety of cancer types linked to tumor survival and/or recurrence. Consequently, several approaches are being explored to regulate this metabolic dysregulation to subvert its tumorigenic properties in different types of cancers. The present review details the significance of lipid metabolism in cancer progression, the critical enzymes involved therein, and their regulation. Moreover, the current findings of the interplay between the oncogenic pathways and the lipid metabolic enzymes are elucidated briefly. The therapeutic implications of modulating these aberrations for the advancement of anti-cancer therapies are also discussed. Although the understanding of altered lipid metabolism in cancer initiation and progression is still in its infancy and somewhat obscure, its in-depth comprehension will open promising therapeutic opportunities for the development of novel and promising strategies for cancer treatment and management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available